CHROMINST Trademark

Trademark Overview


On Friday, November 23, 2018, a trademark application was filed for CHROMINST with the United States Patent and Trademark Office. The USPTO has given the CHROMINST trademark a serial number of 79251431. The federal status of this trademark filing is REGISTERED as of Tuesday, September 3, 2019. This trademark is owned by Shanghai Xukang Medical Science & Technology Co., Ltd. The CHROMINST trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Genic diagnostic reagents for medical purposes; medical diagnostic reagents for gene amplification and detection purposes; medicines for humans, namely, medicinal preparations for the treatment of infectious diseases and for use in oncology; pharmaceutical preparations for wounds; chemico-pharmaceutical preparations for the treatment of digestive system disease, liver disease, anemia, cardiovascular disease, tumors; chemical preparations for the diagnosis of pregnancy; diagnostic preparations for medical purposes; dietetic substances in the nature of foods and beverages adapted for medical use; biological preparations for medical purposes, namely, for the treatment of cancer

Medical services, namely, gene therapy services; medical assistance; medical clinic services; convalescent home services; in vitro fertilization services; in vitro fertilization services for animals; medical equipment rental; massage
chrominst

General Information


Serial Number79251431
Word MarkCHROMINST
Filing DateFriday, November 23, 2018
Status700 - REGISTERED
Status DateTuesday, September 3, 2019
Registration Number5847825
Registration DateTuesday, September 3, 2019
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, June 18, 2019

Trademark Statements


Goods and ServicesGenic diagnostic reagents for medical purposes; medical diagnostic reagents for gene amplification and detection purposes; medicines for humans, namely, medicinal preparations for the treatment of infectious diseases and for use in oncology; pharmaceutical preparations for wounds; chemico-pharmaceutical preparations for the treatment of digestive system disease, liver disease, anemia, cardiovascular disease, tumors; chemical preparations for the diagnosis of pregnancy; diagnostic preparations for medical purposes; dietetic substances in the nature of foods and beverages adapted for medical use; biological preparations for medical purposes, namely, for the treatment of cancer
Pseudo MarkCHROM INST
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical services, namely, gene therapy services; medical assistance; medical clinic services; convalescent home services; in vitro fertilization services; in vitro fertilization services for animals; medical equipment rental; massage

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 12, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 12, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameShanghai Xukang Medical Science & Technology Co., Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCN

Party NameShanghai Xukang Medical Science & Technology Co., Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameShanghai Xukang Medical Science & Technology Co., Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Monday, February 25, 2019ASSIGNED TO EXAMINER
Thursday, February 7, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, February 12, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 16, 2019APPLICATION FILING RECEIPT MAILED
Monday, February 25, 2019NON-FINAL ACTION WRITTEN
Tuesday, February 26, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, March 6, 2019REFUSAL PROCESSED BY MPU
Wednesday, March 6, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, March 23, 2019REFUSAL PROCESSED BY IB
Friday, April 26, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 26, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 26, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 30, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, April 30, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 30, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, April 30, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 15, 2019ASSIGNED TO LIE
Wednesday, May 29, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 12, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, June 18, 2019PUBLISHED FOR OPPOSITION
Tuesday, June 18, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, June 28, 2019NOTIFICATION PROCESSED BY IB
Tuesday, September 3, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, December 3, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, January 6, 2020GENERIC MADRID TRANSACTION CREATED
Tuesday, April 30, 2019EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 12, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Monday, January 6, 2020GENERIC MADRID TRANSACTION SENT TO IB
Tuesday, September 3, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, February 14, 2020FINAL DECISION TRANSACTION PROCESSED BY IB